Gene editing for corneal disease management
|
摘要
Gene editing has recently emerged as a promising technology to engineer genetic modifications precisely in the genome to achieve long-term relief from corneal disorders.Recent advances in the molecular biology leading to the development of clustered regularly interspaced short palindromic repeats(CRISPRs) and CRISPR-associated systems,zinc finger nucleases and transcription activator like effector nucleases have ushered in a new era for high throughput in vitro and in vivo genome engineering.Genome editing can be successfully used to decipher complex molecular mechanisms underlying disease pathophysiology,develop innovative next generation gene therapy,stem cell-based regenerative therapy,and personalized medicine for corneal and other ocular diseases.In this review we describe latest developments in the field of genome editing,current challenges,and future prospects for the development of personalized genebased medicine for corneal diseases.The gene editing approach is expected to revolutionize current diagnostic and treatment practices for curing blindness.
Gene editing has recently emerged as a promising technology to engineer genetic modifications precisely in the genome to achieve long-term relief from corneal disorders.Recent advances in the molecular biology leading to the development of clustered regularly interspaced short palindromic repeats(CRISPRs) and CRISPR-associated systems,zinc finger nucleases and transcription activator like effector nucleases have ushered in a new era for high throughput in vitro and in vivo genome engineering.Genome editing can be successfully used to decipher complex molecular mechanisms underlying disease pathophysiology,develop innovative next generation gene therapy,stem cell-based regenerative therapy,and personalized medicine for corneal and other ocular diseases.In this review we describe latest developments in the field of genome editing,current challenges,and future prospects for the development of personalized genebased medicine for corneal diseases.The gene editing approach is expected to revolutionize current diagnostic and treatment practices for curing blindness.
Gene editing has recently emerged as a promising technology to engineer genetic modifications precisely in the genome to achieve long-term relief from corneal disorders.Recent advances in the molecular biology leading to the development of clustered regularly interspaced short palindromic repeats(CRISPRs) and CRISPR-associated systems,zinc finger nucleases and transcription activator like effector nucleases have ushered in a new era for high throughput in vitro and in vivo genome engineering.Genome editing can be successfully used to decipher complex molecular mechanisms underlying disease pathophysiology,develop innovative next generation gene therapy,stem cell-based regenerative therapy,and personalized medicine for corneal and other ocular diseases.In this review we describe latest developments in the field of genome editing,current challenges,and future prospects for the development of personalized genebased medicine for corneal diseases.The gene editing approach is expected to revolutionize current diagnostic and treatment practices for curing blindness.
引文
1 Chaurasia SS,Lim RR,Lakshminarayanan R,Mohan RR.Nanomedicine approaches for corneal diseases.J Funct Biomater2015;6:277-298[PMID:25941990 DOI:10.3390/jfb6020277]
2 Burton MJ,Mabey DC.The global burden of trachoma:a review.PLo S Negl Trop Dis 2009;3:e460[PMID:19859534 DOI:10.1371/journal.pntd.0000460]
3 Whitcher JP,Srinivasan M,Upadhyay MP.Corneal blindness:a global perspective.Bull World Health Organ 2001;79:214-221[PMID:11285665]
4 Mohan RR,Rodier JT,Sharma A.Corneal gene therapy:basic science and translational perspective.Ocul Surf 2013;11:150-164[PMID:23838017 DOI:10.1016/j.jtos.2012.10.004]
5 Mohan RR,Schultz GS,Hong JW,Mohan RR,Wilson SE.Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.Exp Eye Res 2003;76:373-383[PMID:12573666]
6 Mohan RR,Sharma A,Cebulko TC,Tandon A.Vector delivery technique affects gene transfer in the cornea in vivo.Mol Vis 2010;16:2494-2501[PMID:21139995]
7 Mohan RR,Sinha S,Tandon A,Gupta R,Tovey JC,Sharma A.Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.PLo S One 2011;6:e18771[PMID:21533273 DOI:10.1371/journal.pone.0018771]
8 Mohan RR,Tandon A,Sharma A,Cowden JW,Tovey JC.Significant inhibition of corneal scarring in vivo with tissue-selective,targeted AAV5 decorin gene therapy.Invest Ophthalmol Vis Sci 2011;52:4833-4841[PMID:21551414 DOI:10.1167/iovs.11-7357]
9 Mohan RR,Tovey JC,Sharma A,Schultz GS,Cowden JW,Tandon A.Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.PLo S One 2011;6:e26432[PMID:22039486 DOI:10.1371/journal.pone.0026432]
10 Tandon A,Sharma A,Rodier JT,Klibanov AM,Rieger FG,Mohan RR.BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo.PLo S One 2013;8:e66434[PMID:23799103 DOI:10.1371/journal.pone.0066434]
11 Sharma A,Tandon A,Tovey JC,Gupta R,Robertson JD,Fortune JA,Klibanov AM,Cowden JW,Rieger FG,Mohan RR.Polyethylenimine-conjugated gold nanoparticles:Gene transfer potential and low toxicity in the cornea.Nanomedicine 2011;7:505-513[PMID:21272669 DOI:10.1016/j.nano.2011.01.006]
12 Smithies O,Gregg RG,Boggs SS,Koralewski MA,Kucherlapati RS.Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination.Nature 1985;317:230-234[PMID:2995814]
13 Thomas KR,Capecchi MR.Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.Cell 1987;51:503-512[PMID:2822260]
14 Vasquez KM,Marburger K,Intody Z,Wilson JH.Manipulating the mammalian genome by homologous recombination.Proc Natl Acad Sci USA 2001;98:8403-8410[PMID:11459982 DOI:10.1073/pnas.111009698]
15 Jackson AL,Bartz SR,Schelter J,Kobayashi SV,Burchard J,Mao M,Li B,Cavet G,Linsley PS.Expression profiling reveals offtarget gene regulation by RNAi.Nat Biotechnol 2003;21:635-637[PMID:12754523 DOI:10.1038/nbt831]
16 Birmingham A,Anderson EM,Reynolds A,Ilsley-Tyree D,Leake D,Fedorov Y,Baskerville S,Maksimova E,Robinson K,Karpilow J,Marshall WS,Khvorova A.3’UTR seed matches,but not overall identity,are associated with RNAi off-targets.Nat Methods 2006;3:199-204[PMID:16489337 DOI:10.1038/nmeth854]
17 Fedorov Y,Anderson EM,Birmingham A,Reynolds A,Karpilow J,Robinson K,Leake D,Marshall WS,Khvorova A.Off-target effects by si RNA can induce toxic phenotype.RNA 2006;12:1188-1196[PMID:16682561 DOI:10.1261/rna.28106]
18 Khan AA,Betel D,Miller ML,Sander C,Leslie CS,Marks DS.Transfection of small RNAs globally perturbs gene regulation by endogenous micro RNAs.Nat Biotechnol 2009;27:549-555[PMID:19465925 DOI:10.1038/nbt.1543]
19 Sledz CA,Holko M,de Veer MJ,Silverman RH,Williams BR.Activation of the interferon system by short-interfering RNAs.Nat Cell Biol 2003;5:834-839[PMID:12942087 DOI:10.1038/ncb1038]
20 Kim YG,Chandrasegaran S.Chimeric restriction endonuclease.Proc Natl Acad Sci USA 1994;91:883-887[PMID:7905633]
21 Kim YG,Li L,Chandrasegaran S.Insertion and deletion mutants of Fok I restriction endonuclease.J Biol Chem 1994;269:31978-31982[PMID:7989374]
22 Kim SS,Chen YM,O’Leary E,Witzgall R,Vidal M,Bonventre JV.A novel member of the RING finger family,KRIP-1,associates with the KRAB-A transcriptional repressor domain of zinc finger proteins.Proc Natl Acad Sci USA 1996;93:15299-15304[PMID:8986806]
23 Kim YG,Cha J,Chandrasegaran S.Hybrid restriction enzymes:zinc finger fusions to Fok I cleavage domain.Proc Natl Acad Sci USA 1996;93:1156-1160[PMID:8577732]
24 Carroll D.Genome engineering with targetable nucleases.Annu Rev Biochem 2014;83:409-439[PMID:24606144 DOI:10.1146/annurev-biochem-060713-035418]
25 Urnov FD,Rebar EJ,Holmes MC,Zhang HS,Gregory PD.Genome editing with engineered zinc finger nucleases.Nat Rev Genet 2010;11:636-646[PMID:20717154 DOI:10.1038/nrg2842]
26 Jackson SP,Bartek J.The DNA-damage response in human biology and disease.Nature 2009;461:1071-1078[PMID:19847258 DOI:10.1038/nature08467]
27 Moynahan ME,Jasin M.Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.Nat Rev Mol Cell Biol 2010;11:196-207[PMID:20177395 DOI:10.1038/nrm2851]
28 Lieber MR.The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.Annu Rev Biochem2010;79:181-211[PMID:20192759 DOI:10.1146/annurev.biochem.052308.093131]
29 Urnov FD,Miller JC,Lee YL,Beausejour CM,Rock JM,Augustus S,Jamieson AC,Porteus MH,Gregory PD,Holmes MC.Highly efficient endogenous human gene correction using designed zinc-finger nucleases.Nature 2005;435:646-651[PMID:15806097 DOI:10.1038/nature03556]
30 Deng H,Liu R,Ellmeier W,Choe S,Unutmaz D,Burkhart M,Di Marzio P,Marmon S,Sutton RE,Hill CM,Davis CB,Peiper SC,Schall TJ,Littman DR,Landau NR.Identification of a major coreceptor for primary isolates of HIV-1.Nature 1996;381:661-666[PMID:8649511 DOI:10.1038/381661a0]
31 Alkhatib G,Combadiere C,Broder CC,Feng Y,Kennedy PE,Murphy PM,Berger EA.CC CKR5:a RANTES,MIP-1alpha,MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.Science 1996;272:1955-1958[PMID:8658171]
32 Hütter G,Nowak D,Mossner M,Ganepola S,Müssig A,Allers K,Schneider T,Hofmann J,Kücherer C,Blau O,Blau IW,Hofmann WK,Thiel E.Long-term control of HIV by CCR5 Delta32/Delta32stem-cell transplantation.N Engl J Med 2009;360:692-698[PMID:19213682 DOI:10.1056/NEJMoa0802905]
33 Li L,Krymskaya L,Wang J,Henley J,Rao A,Cao LF,Tran CA,Torres-Coronado M,Gardner A,Gonzalez N,Kim K,Liu PQ,Hofer U,Lopez E,Gregory PD,Liu Q,Holmes MC,Cannon PM,Zaia JA,Di Giusto DL.Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.Mol Ther 2013;21:1259-1269[PMID:23587921DOI:10.1038/mt.2013.65]
34 Holt N,Wang J,Kim K,Friedman G,Wang X,Taupin V,Crooks GM,Kohn DB,Gregory PD,Holmes MC,Cannon PM.Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.Nat Biotechnol2010;28:839-847[PMID:20601939 DOI:10.1038/nbt.1663]
35 Perez EE,Wang J,Miller JC,Jouvenot Y,Kim KA,Liu O,Wang N,Lee G,Bartsevich VV,Lee YL,Guschin DY,Rupniewski I,Waite AJ,Carpenito C,Carroll RG,Orange JS,Urnov FD,Rebar EJ,Ando D,Gregory PD,Riley JL,Holmes MC,June CH.Establishment of HIV-1 resistance in CD4+T cells by genome editing using zinc-finger nucleases.Nat Biotechnol 2008;26:808-816[PMID:18587387 DOI:10.1038/nbt1410]
36 Tebas P,Stein D,Tang WW,Frank I,Wang SQ,Lee G,Spratt SK,Surosky RT,Giedlin MA,Nichol G,Holmes MC,Gregory PD,Ando DG,Kalos M,Collman RG,Binder-Scholl G,Plesa G,Hwang WT,Levine BL,June CH.Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.N Engl J Med 2014;370:901-910[PMID:24597865 DOI:10.1056/NEJMoa1300662]
37 Doyon Y,Vo TD,Mendel MC,Greenberg SG,Wang J,Xia DF,Miller JC,Urnov FD,Gregory PD,Holmes MC.Enhancing zincfinger-nuclease activity with improved obligate heterodimeric architectures.Nat Methods 2011;8:74-79[PMID:21131970 DOI:10.1038/nmeth.1539]
38 Miller JC,Holmes MC,Wang J,Guschin DY,Lee YL,Rupniewski I,Beausejour CM,Waite AJ,Wang NS,Kim KA,Gregory PD,Pabo CO,Rebar EJ.An improved zinc-finger nuclease architecture for highly specific genome editing.Nat Biotechnol 2007;25:778-785[PMID:17603475 DOI:10.1038/nbt1319]
39 Szczepek M,Brondani V,Büchel J,Serrano L,Segal DJ,Cathomen T.Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases.Nat Biotechnol 2007;25:786-793[PMID:17603476 DOI:10.1038/nbt1317]
40 Boch J,Scholze H,Schornack S,Landgraf A,Hahn S,Kay S,Lahaye T,Nickstadt A,Bonas U.Breaking the code of DNA binding specificity of TAL-type III effectors.Science 2009;326:1509-1512[PMID:19933107 DOI:10.1126/science.1178811]
41 Kay S,Hahn S,Marois E,Hause G,Bonas U.A bacterial effector acts as a plant transcription factor and induces a cell size regulator.Science2007;318:648-651[PMID:17962565 DOI:10.1126/science.1144956]
42 R?mer P,Hahn S,Jordan T,Strauss T,Bonas U,Lahaye T.Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene.Science 2007;318:645-648[PMID:17962564 DOI:10.1126/science.1144958]
43 Bogdanove AJ,Voytas DF.TAL effectors:customizable proteins for DNA targeting.Science 2011;333:1843-1846[PMID:21960622DOI:10.1126/science.1204094]
44 Moscou MJ,Bogdanove AJ.A simple cipher governs DNA recognition by TAL effectors.Science 2009;326:1501[PMID:19933106 DOI:10.1126/science.1178817]
45 Hockemeyer D,Wang H,Kiani S,Lai CS,Gao Q,Cassady JP,Cost GJ,Zhang L,Santiago Y,Miller JC,Zeitler B,Cherone JM,Meng X,Hinkley SJ,Rebar EJ,Gregory PD,Urnov FD,Jaenisch R.Genetic engineering of human pluripotent cells using TALE nucleases.Nat Biotechnol 2011;29:731-734[PMID:21738127DOI:10.1038/nbt.1927]
46 Miller JC,Tan S,Qiao G,Barlow KA,Wang J,Xia DF,Meng X,Paschon DE,Leung E,Hinkley SJ,Dulay GP,Hua KL,Ankoudinova I,Cost GJ,Urnov FD,Zhang HS,Holmes MC,Zhang L,Gregory PD,Rebar EJ.A TALE nuclease architecture for efficient genome editing.Nat Biotechnol 2011;29:143-148[PMID:21179091 DOI:10.1038/nbt.1755]
47 Zhang F,Cong L,Lodato S,Kosuri S,Church GM,Arlotta P.Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription.Nat Biotechnol 2011;29:149-153[PMID:21248753 DOI:10.1038/nbt.1775]
48 Reyon D,Tsai SQ,Khayter C,Foden JA,Sander JD,Joung JK.FLASH assembly of TALENs for high-throughput genome editing.Nat Biotechnol 2012;30:460-465[PMID:22484455 DOI:10.1038/nbt.2170]
49 Huang P,Xiao A,Zhou M,Zhu Z,Lin S,Zhang B.Heritable gene targeting in zebrafish using customized TALENs.Nat Biotechnol2011;29:699-700[PMID:21822242 DOI:10.1038/nbt.1939]
50 Sander JD,Cade L,Khayter C,Reyon D,Peterson RT,Joung JK,Yeh JR.Targeted gene disruption in somatic zebrafish cells using engineered TALENs.Nat Biotechnol 2011;29:697-698[PMID:21822241 DOI:10.1038/nbt.1934]
51 Tesson L,Usal C,Ménoret S,Leung E,Niles BJ,Remy S,Santiago Y,Vincent AI,Meng X,Zhang L,Gregory PD,Anegon I,Cost GJ.Knockout rats generated by embryo microinjection of TALENs.Nat Biotechnol 2011;29:695-696[PMID:21822240DOI:10.1038/nbt.1940]
52 Wood AJ,Lo TW,Zeitler B,Pickle CS,Ralston EJ,Lee AH,Amora R,Miller JC,Leung E,Meng X,Zhang L,Rebar EJ,Gregory PD,Urnov FD,Meyer BJ.Targeted genome editing across species using ZFNs and TALENs.Science 2011;333:307[PMID:21700836 DOI:10.1126/science.1207773]
53 Deml B,Kariminejad A,Borujerdi RH,Muheisen S,Reis LM,Semina EV.Mutations in MAB21L2 result in ocular Coloboma,microcornea and cataracts.PLo S Genet 2015;11:e1005002[PMID:25719200 DOI:10.1371/journal.pgen.1005002]
54 Park CY,Kim J,Kweon J,Son JS,Lee JS,Yoo JE,Cho SR,Kim JH,Kim JS,Kim DW.Targeted inversion and reversion of the blood coagulation factor 8 gene in human i PS cells using TALENs.Proc Natl Acad Sci USA 2014;111:9253-9258[PMID:24927536DOI:10.1073/pnas.1323941111]
55 Ye L,Wang J,Beyer AI,Teque F,Cradick TJ,Qi Z,Chang JC,Bao G,Muench MO,Yu J,Levy JA,Kan YW.Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32mutation confers resistance to HIV infection.Proc Natl Acad Sci USA 2014;111:9591-9596[PMID:24927590 DOI:10.1073/pnas.1407473111]
56 Low BE,Krebs MP,Joung JK,Tsai SQ,Nishina PM,Wiles MV.Correction of the Crb1rd8 allele and retinal phenotype in C57BL/6 N mice via TALEN-mediated homology-directed repair.Invest Ophthalmol Vis Sci 2014;55:387-395[PMID:24346171 DOI:10.1167/iovs.13-13278]
57 Panda SK,Wefers B,Ortiz O,Floss T,Schmid B,Haass C,Wurst W,Kühn R.Highly efficient targeted mutagenesis in mice using TALENs.Genetics 2013;195:703-713[PMID:23979585 DOI:10.1534/genetics.113.156570]
58 Reddy P,Ocampo A,Suzuki K,Luo J,Bacman SR,Williams SL,Sugawara A,Okamura D,Tsunekawa Y,Wu J,Lam D,Xiong X,Montserrat N,Esteban CR,Liu GH,Sancho-Martinez I,Manau D,Civico S,Cardellach F,Del Mar O’Callaghan M,Campistol J,Zhao H,Campistol JM,Moraes CT,Izpisua Belmonte JC.Selective elimination of mitochondrial mutations in the germline by genome editing.Cell 2015;161:459-469[PMID:25910206DOI:10.1016/j.cell.2015.03.051]
59 Bacman SR,Williams SL,Pinto M,Peralta S,Moraes CT.Specific elimination of mutant mitochondrial genomes in patientderived cells by mito TALENs.Nat Med 2013;19:1111-1113[PMID:23913125 DOI:10.1038/nm.3261]
60 Li HL,Fujimoto N,Sasakawa N,Shirai S,Ohkame T,Sakuma T,Tanaka M,Amano N,Watanabe A,Sakurai H,Yamamoto T,Yamanaka S,Hotta A.Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.Stem Cell Reports 2015;4:143-154[PMID:25434822 DOI:10.1016/j.stemcr.2014.10.013]
61 Ding Q,Lee YK,Schaefer EA,Peters DT,Veres A,Kim K,Kuperwasser N,Motola DL,Meissner TB,Hendriks WT,Trevisan M,Gupta RM,Moisan A,Banks E,Friesen M,Schinzel RT,Xia F,Tang A,Xia Y,Figueroa E,Wann A,Ahfeldt T,Daheron L,Zhang F,Rubin LL,Peng LF,Chung RT,Musunuru K,Cowan CA.A TALEN genome-editing system for generating human stem cellbased disease models.Cell Stem Cell 2013;12:238-251[PMID:23246482 DOI:10.1016/j.stem.2012.11.011]
62 Kim Y,Kweon J,Kim A,Chon JK,Yoo JY,Kim HJ,Kim S,Lee C,Jeong E,Chung E,Kim D,Lee MS,Go EM,Song HJ,Kim H,Cho N,Bang D,Kim S,Kim JS.A library of TAL effector nucleases spanning the human genome.Nat Biotechnol 2013;31:251-258[PMID:23417094 DOI:10.1038/nbt.2517]
63 Menon T,Firth AL,Scripture-Adams DD,Galic Z,Qualls SJ,Gilmore WB,Ke E,Singer O,Anderson LS,Bornzin AR,Alexander IE,Zack JA,Verma IM.Lymphoid regeneration from genecorrected SCID-X1 subject-derived i PSCs.Cell Stem Cell 2015;16:367-372[PMID:25772073 DOI:10.1016/j.stem.2015.02.005]
64 Hu Z,Ding W,Zhu D,Yu L,Jiang X,Wang X,Zhang C,Wang L,Ji T,Liu D,He D,Xia X,Zhu T,Wei J,Wu P,Wang C,Xi L,Gao Q,Chen G,Liu R,Li K,Li S,Wang S,Zhou J,Ma D,Wang H.TALEN-mediated targeting of HPV oncogenes ameliorates HPVrelated cervical malignancy.J Clin Invest 2015;125:425-436[PMID:25500889 DOI:10.1172/JCI78206]
65 Cong L,Ran FA,Cox D,Lin S,Barretto R,Habib N,Hsu PD,Wu X,Jiang W,Marraffini LA,Zhang F.Multiplex genome engineering using CRISPR/Cas systems.Science 2013;339:819-823[PMID:23287718 DOI:10.1126/science.1231143]
66 Jinek M,Chylinski K,Fonfara I,Hauer M,Doudna JA,Charpentier E.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.Science 2012;337:816-821[PMID:22745249 DOI:10.1126/science.1225829]
67 Mali P,Aach J,Stranges PB,Esvelt KM,Moosburner M,Kosuri S,Yang L,Church GM.CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.Nat Biotechnol 2013;31:833-838[PMID:23907171DOI:10.1038/nbt.2675]
68 Mali P,Esvelt KM,Church GM.Cas9 as a versatile tool for engineering biology.Nat Methods 2013;10:957-963[PMID:24076990 DOI:10.1038/nmeth.2649]
69 Mali P,Yang L,Esvelt KM,Aach J,Guell M,Di Carlo JE,Norville JE,Church GM.RNA-guided human genome engineering via Cas9.Science 2013;339:823-826[PMID:23287722 DOI:10.1126/science.1232033]
70 Sternberg SH,Redding S,Jinek M,Greene EC,Doudna JA.DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.Nature 2014;507:62-67[PMID:24476820 DOI:10.1038/nature13011]
71 Sánchez-Rivera FJ,Jacks T.Applications of the CRISPR-Cas9system in cancer biology.Nat Rev Cancer 2015;15:387-395[PMID:26040603 DOI:10.1038/nrc3950]
72 Sánchez-Rivera FJ,Papagiannakopoulos T,Romero R,Tammela T,Bauer MR,Bhutkar A,Joshi NS,Subbaraj L,Bronson RT,Xue W,Jacks T.Rapid modelling of cooperating genetic events in cancer through somatic genome editing.Nature 2014;516:428-431[PMID:25337879 DOI:10.1038/nature13906]
73 Swiech L,Heidenreich M,Banerjee A,Habib N,Li Y,Trombetta J,Sur M,Zhang F.In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.Nat Biotechnol 2015;33:102-106[PMID:25326897 DOI:10.1038/nbt.3055]
74 Wang T,Wei JJ,Sabatini DM,Lander ES.Genetic screens in human cells using the CRISPR-Cas9 system.Science 2014;343:80-84[PMID:24336569 DOI:10.1126/science.1246981]
75 Wang H,Yang H,Shivalila CS,Dawlaty MM,Cheng AW,Zhang F,Jaenisch R.One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.Cell 2013;153:910-918[PMID:23643243 DOI:10.1016/j.cell.2013.04.025]
76 Zhou Y,Zhu S,Cai C,Yuan P,Li C,Huang Y,Wei W.Highthroughput screening of a CRISPR/Cas9 library for functional genomics in human cells.Nature 2014;509:487-491[PMID:24717434 DOI:10.1038/nature13166]
77 Shalem O,Sanjana NE,Hartenian E,Shi X,Scott DA,Mikkelsen TS,Heckl D,Ebert BL,Root DE,Doench JG,Zhang F.Genomescale CRISPR-Cas9 knockout screening in human cells.Science2014;343:84-87[PMID:24336571 DOI:10.1126/science.1247005]
78 Platt RJ,Chen S,Zhou Y,Yim MJ,Swiech L,Kempton HR,Dahlman JE,Parnas O,Eisenhaure TM,Jovanovic M,Graham DB,Jhunjhunwala S,Heidenreich M,Xavier RJ,Langer R,Anderson DG,Hacohen N,Regev A,Feng G,Sharp PA,Zhang F.CRISPR-Cas9 knockin mice for genome editing and cancer modeling.Cell 2014;159:440-455[PMID:25263330 DOI:10.1016/j.cell.2014.09.014]
79 Yu Z,Ren M,Wang Z,Zhang B,Rong YS,Jiao R,Gao G.Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila.Genetics 2013;195:289-291[PMID:23833182 DOI:10.1534/genetics.113.153825]
80 Friedland AE,Tzur YB,Esvelt KM,Colaiácovo MP,Church GM,Calarco JA.Heritable genome editing in C.elegans via a CRISPRCas9 system.Nat Methods 2013;10:741-743[PMID:23817069DOI:10.1038/nmeth.2532]
81 Dickinson DJ,Ward JD,Reiner DJ,Goldstein B.Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination.Nat Methods 2013;10:1028-1034[PMID:23995389 DOI:10.1038/nmeth.2641]
82 Cho SW,Kim S,Kim JM,Kim JS.Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.Nat Biotechnol 2013;31:230-232[PMID:23360966 DOI:10.1038/nbt.2507]
83 Hwang WY,Fu Y,Reyon D,Maeder ML,Tsai SQ,Sander JD,Peterson RT,Yeh JR,Joung JK.Efficient genome editing in zebrafish using a CRISPR-Cas system.Nat Biotechnol 2013;31:227-229[PMID:23360964 DOI:10.1038/nbt.2501]
84 Li D,Qiu Z,Shao Y,Chen Y,Guan Y,Liu M,Li Y,Gao N,Wang L,Lu X,Zhao Y,Liu M.Heritable gene targeting in the mouse and rat using a CRISPR-Cas system.Nat Biotechnol 2013;31:681-683[PMID:23929336 DOI:10.1038/nbt.2661]
85 Li W,Teng F,Li T,Zhou Q.Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems.Nat Biotechnol 2013;31:684-686[PMID:23929337DOI:10.1038/nbt.2652]
86 Yang H,Wang H,Shivalila CS,Cheng AW,Shi L,Jaenisch R.Onestep generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.Cell 2013;154:1370-1379[PMID:23992847 DOI:10.1016/j.cell.2013.08.022]
87 Hall AB,Basu S,Jiang X,Qi Y,Timoshevskiy VA,Biedler JK,Sharakhova MV,Elahi R,Anderson MA,Chen XG,Sharakhov IV,Adelman ZN,Tu Z.SEX DETERMINATION.A maledetermining factor in the mosquito Aedes aegypti.Science 2015;348:1268-1270[PMID:25999371 DOI:10.1126/science.aaa2850]
88 Kistler KE,Vosshall LB,Matthews BJ.Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti.Cell Rep 2015;11:51-60[PMID:25818303 DOI:10.1016/j.celrep.2015.03.009]
89 Dong S,Lin J,Held NL,Clem RJ,Passarelli AL,Franz AW.Heritable CRISPR/Cas9-mediated genome editing in the yellow fever mosquito,Aedes aegypti.PLo S One 2015;10:e0122353[PMID:25815482 DOI:10.1371/journal.pone.0122353]
90 Basu S,Aryan A,Overcash JM,Samuel GH,Anderson MA,Dahlem TJ,Myles KM,Adelman ZN.Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti.Proc Natl Acad Sci USA 2015;112:4038-4043[PMID:25775608 DOI:10.1073/pnas.1502370112]
91 Gasiunas G,Barrangou R,Horvath P,Siksnys V.Cas9-cr RNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.Proc Natl Acad Sci USA 2012;109:E2579-E2586[PMID:22949671 DOI:10.1073/pnas.1208507109]
92 Sapranauskas R,Gasiunas G,Fremaux C,Barrangou R,Horvath P,Siksnys V.The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.Nucleic Acids Res 2011;39:9275-9282[PMID:21813460 DOI:10.1093/nar/gkr606]
93 Chen Y,Cao J,Xiong M,Petersen AJ,Dong Y,Tao Y,Huang CT,Du Z,Zhang SC.Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.Cell Stem Cell 2015;17:233-244[PMID:26145478 DOI:10.1016/j.stem.2015.06.001]
94 Wu Y,Liang D,Wang Y,Bai M,Tang W,Bao S,Yan Z,Li D,Li J.Correction of a genetic disease in mouse via use of CRISPRCas9.Cell Stem Cell 2013;13:659-662[PMID:24315440 DOI:10.1016/j.stem.2013.10.016]
95 Courtney DG,Moore JE,Atkinson SD,Maurizi E,Allen EH,Pedrioli DM,Mc Lean WH,Nesbit MA,Moore CB.CRISPR/Cas9DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting.Gene Ther 2016;23:108-112[PMID:26289666 DOI:10.1038/gt.2015.82]
96 Zhong H,Chen Y,Li Y,Chen R,Mardon G.CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes.Sci Rep 2015;5:8366[PMID:25666713 DOI:10.1038/srep08366]
97 Mohan RR,Sharma A,Netto MV,Sinha S,Wilson SE.Gene therapy in the cornea.Prog Retin Eye Res 2005;24:537-559[PMID:15955719 DOI:10.1016/j.preteyeres.2005.04.001]
98 Ran FA,Cong L,Yan WX,Scott DA,Gootenberg JS,Kriz AJ,Zetsche B,Shalem O,Wu X,Makarova KS,Koonin EV,Sharp PA,Zhang F.In vivo genome editing using Staphylococcus aureus Cas9.Nature 2015;520:186-191[PMID:25830891 DOI:10.1038/nature14299]
99 Ran FA,Hsu PD,Lin CY,Gootenberg JS,Konermann S,Trevino AE,Scott DA,Inoue A,Matoba S,Zhang Y,Zhang F.Double nicking by RNA-guided CRISPR Cas9 for enhanced genomeediting specificity.Cell 2013;154:1380-1389[PMID:23992846DOI:10.1016/j.cell.2013.08.021]
100 Suzuki K,Yu C,Qu J,Li M,Yao X,Yuan T,Goebl A,Tang S,Ren R,Aizawa E,Zhang F,Xu X,Soligalla RD,Chen F,Kim J,Kim NY,Liao HK,Benner C,Esteban CR,Jin Y,Liu GH,Li Y,Izpisua Belmonte JC.Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.Cell Stem Cell 2014;15:31-36[PMID:24996168 DOI:10.1016/j.stem.2014.06.016]
101 Nihongaki Y,Kawano F,Nakajima T,Sato M.Photoactivatable CRISPR-Cas9 for optogenetic genome editing.Nat Biotechnol2015;33:755-760[PMID:26076431 DOI:10.1038/nbt.3245]
102 Zetsche B,Gootenberg Jonathan S,Abudayyeh Omar O,Slaymaker Ian M,Makarova Kira S,Essletzbichler P,Volz Sara E,Joung J,van der Oost J,Regev A,Koonin Eugene V,Zhang F.Cpf1Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System.Cell 2015;163:759-771[DOI:10.1016/j.cell.2015.09.038]
103 Liang P,Xu Y,Zhang X,Ding C,Huang R,Zhang Z,Lv J,Xie X,Chen Y,Li Y,Sun Y,Bai Y,Songyang Z,Ma W,Zhou C,Huang J.CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.Protein Cell 2015;6:363-372[PMID:25894090 DOI:10.1007/s13238-015-0153-5]
104 Chang CJ,Bouhassira EE.Zinc-finger nuclease-mediated correction ofα-thalassemia in i PS cells.Blood 2012;120:3906-3914[PMID:23002118 DOI:10.1182/blood-2012-03-420703]
105 Chen YG,Forsberg MH,Khaja S,Ciecko AE,Hessner MJ,Geurts AM.Gene targeting in NOD mouse embryos using zinc-finger nucleases.Diabetes 2014;63:68-74[PMID:23974926 DOI:10.2337/db13-0192]
106 Cradick TJ,Keck K,Bradshaw S,Jamieson AC,Mc Caffrey AP.Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs.Mol Ther 2010;18:947-954[PMID:20160705 DOI:10.1038/mt.2010.20]
107 Didigu CA,Wilen CB,Wang J,Duong J,Secreto AJ,DanetDesnoyers GA,Riley JL,Gregory PD,June CH,Holmes MC,Doms RW.Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+T cells from HIV-1infection.Blood 2014;123:61-69[PMID:24162716 DOI:10.1182/blood-2013-08-521229]
108 Lombardo A,Genovese P,Beausejour CM,Colleoni S,Lee YL,Kim KA,Ando D,Urnov FD,Galli C,Gregory PD,Holmes MC,Naldini L.Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.Nat Biotechnol 2007;25:1298-1306[PMID:17965707 DOI:10.1038/nbt1353]
109 Provasi E,Genovese P,Lombardo A,Magnani Z,Liu PQ,Reik A,Chu V,Paschon DE,Zhang L,Kuball J,Camisa B,Bondanza A,Casorati G,Ponzoni M,Ciceri F,Bordignon C,Greenberg PD,Holmes MC,Gregory PD,Naldini L,Bonini C.Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.Nat Med 2012;18:807-815[PMID:22466705 DOI:10.1038/nm.2700]
110 Sebastiano V,Maeder ML,Angstman JF,Haddad B,Khayter C,Yeo DT,Goodwin MJ,Hawkins JS,Ramirez CL,Batista LF,Artandi SE,Wernig M,Joung JK.In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.Stem Cells 2011;29:1717-1726[PMID:21898685 DOI:10.1002/stem.718]
111 Zou J,Maeder ML,Mali P,Pruett-Miller SM,Thibodeau-Beganny S,Chou BK,Chen G,Ye Z,Park IH,Daley GQ,Porteus MH,Joung JK,Cheng L.Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.Cell Stem Cell 2009;5:97-110[PMID:19540188 DOI:10.1016/j.stem.2009.05.023]
112 Zou J,Sweeney CL,Chou BK,Choi U,Pan J,Wang H,Dowey SN,Cheng L,Malech HL.Oxidase-deficient neutrophils from X-linked chronic granulomatous disease i PS cells:functional correction by zinc finger nuclease-mediated safe harbor targeting.Blood 2011;117:5561-5572[PMID:21411759 DOI:10.1182/blood-2010-12-328161]
113 Sharma R,Anguela XM,Doyon Y,Wechsler T,De Kelver RC,Sproul S,Paschon DE,Miller JC,Davidson RJ,Shivak D,Zhou S,Rieders J,Gregory PD,Holmes MC,Rebar EJ,High KA.In vivo genome editing of the albumin locus as a platform for protein replacement therapy.Blood 2015;126:1777-1784[PMID:26297739 DOI:10.1182/blood-2014-12-615492]
114 Chen W,Liu J,Zhang L,Xu H,Guo X,Deng S,Liu L,Yu D,Chen Y,Li Z.Generation of the SCN1A epilepsy mutation in hi PS cells using the TALEN technique.Sci Rep 2014;4:5404[PMID:24953032 DOI:10.1038/srep05404]
115 Fadel HJ,Morrison JH,Saenz DT,Fuchs JR,Kvaratskhelia M,Ekker SC,Poeschla EM.TALEN knockout of the PSIP1 gene in human cells:analyses of HIV-1 replication and allosteric integrase inhibitor mechanism.J Virol 2014;88:9704-9717[PMID:24942577 DOI:10.1128/JVI.01397-14]
116 Huang X,Wang Y,Yan W,Smith C,Ye Z,Wang J,Gao Y,Mendelsohn L,Cheng L.Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient i PSCs After Genome Editing of the Sickle Point Mutation.Stem Cells 2015;33:1470-1479[PMID:25702619 DOI:10.1002/stem.1969]
117 Dreyer AK,H o ff m a n n D,L a c h m a n n N,A c k e r m a n n M,Steinemann D,Timm B,Siler U,Reichenbach J,Grez M,Moritz T,Schambach A,Cathomen T.TALEN-mediated functional correction of X-linked chronic granulomatous disease in patientderived induced pluripotent stem cells.Biomaterials 2015;69:191-200[PMID:26295532 DOI:10.1016/j.biomaterials.2015.07.057]
118 Zhang S,Li L,Kendrick SL,Gerard RD,Zhu H.TALEN-mediated somatic mutagenesis in murine models of cancer.Cancer Res2014;74:5311-5321[PMID:25070752 DOI:10.1158/0008-5472.CAN-14-0529]
119 Park CY,Kim DH,Son JS,Sung JJ,Lee J,Bae S,Kim JH,Kim DW,Kim JS.Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived i PSCs Using CRISPR-Cas9.Cell Stem Cell 2015;17:213-220[PMID:26212079 DOI:10.1016/j.stem.2015.07.001]
120 Karakikes I,Stillitano F,Nonnenmacher M,Tzimas C,Sanoudou D,Termglinchan V,Kong CW,Rushing S,Hansen J,Ceholski D,Kolokathis F,Kremastinos D,Katoulis A,Ren L,Cohen N,Gho JM,Tsiapras D,Vink A,Wu JC,Asselbergs FW,Li RA,Hulot JS,Kranias EG,Hajjar RJ.Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.Nat Commun 2015;6:6955[PMID:25923014 DOI:10.1038/ncomms7955]
121 Ochiai H,Miyamoto T,Kanai A,Hosoba K,Sakuma T,Kudo Y,Asami K,Ogawa A,Watanabe A,Kajii T,Yamamoto T,Matsuura S.TALEN-mediated single-base-pair editing identification of an intergenic mutation upstream of BUB1B as causative of PCS(MVA)syndrome.Proc Natl Acad Sci USA 2014;111:1461-1466[PMID:24344301 DOI:10.1073/pnas.1317008111]
122 Liu H,Chen Y,Niu Y,Zhang K,Kang Y,Ge W,Liu X,Zhao E,Wang C,Lin S,Jing B,Si C,Lin Q,Chen X,Lin H,Pu X,Wang Y,Qin B,Wang F,Wang H,Si W,Zhou J,Tan T,Li T,Ji S,Xue Z,Luo Y,Cheng L,Zhou Q,Li S,Sun YE,Ji W.TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys.CellStem Cell 2014;14:323-328[PMID:24529597 DOI:10.1016/j.stem.2014.01.018]
123 Wang H,Hu YC,Markoulaki S,Welstead GG,Cheng AW,Shivalila CS,Pyntikova T,Dadon DB,Voytas DF,Bogdanove AJ,Page DC,Jaenisch R.TALEN-mediated editing of the mouse Y chromosome.Nat Biotechnol 2013;31:530-532[PMID:23666012DOI:10.1038/nbt.2595]
124 Ousterout DG,Kabadi AM,Thakore PI,Majoros WH,Reddy TE,Gersbach CA.Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.Nat Commun 2015;6:6244[PMID:25692716 DOI:10.1038/ncomms7244]
125 Osborn MJ,Gabriel R,Webber BR,De Feo AP,Mc Elroy AN,Jarjour J,Starker CG,Wagner JE,Joung JK,Voytas DF,von Kalle C,Schmidt M,Blazar BR,Tolar J.Fanconi anemia gene editing by the CRISPR/Cas9 system.Hum Gene Ther 2015;26:114-126[PMID:25545896 DOI:10.1089/hum.2014.111]
126 Matano M,Date S,Shimokawa M,Takano A,Fujii M,Ohta Y,Watanabe T,Kanai T,Sato T.Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.Nat Med 2015;21:256-262[PMID:25706875 DOI:10.1038/nm.3802]
127 Yin H,Xue W,Chen S,Bogorad RL,Benedetti E,Grompe M,Koteliansky V,Sharp PA,Jacks T,Anderson DG.Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.Nat Biotechnol 2014;32:551-553[PMID:24681508 DOI:10.1038/nbt.2884]
128 Xue W,Chen S,Yin H,Tammela T,Papagiannakopoulos T,Joshi NS,Cai W,Yang G,Bronson R,Crowley DG,Zhang F,Anderson DG,Sharp PA,Jacks T.CRISPR-mediated direct mutation of cancer genes in the mouse liver.Nature 2014;514:380-384[PMID:25119044 DOI:10.1038/nature13589]
129 Long C,Mc Anally JR,Shelton JM,Mireault AA,Bassel-Duby R,Olson EN.Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.Science 2014;345:1184-1188[PMID:25123483 DOI:10.1126/science.1254445]
130 Mandal PK,Ferreira LM,Collins R,Meissner TB,Boutwell CL,Friesen M,Vrbanac V,Garrison BS,Stortchevoi A,Bryder D,Musunuru K,Brand H,Tager AM,Allen TM,Talkowski ME,Rossi DJ,Cowan CA.Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.Cell Stem Cell 2014;15:643-652[PMID:25517468 DOI:10.1016/j.stem.2014.10.004]
131 Schwank G,Koo BK,Sasselli V,Dekkers JF,Heo I,Demircan T,Sasaki N,Boymans S,Cuppen E,van der Ent CK,Nieuwenhuis EE,Beekman JM,Clevers H.Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.Cell Stem Cell 2013;13:653-658[PMID:24315439 DOI:10.1016/j.stem.2013.11.002]
132 Vinayak S,Pawlowic MC,Sateriale A,Brooks CF,Studstill CJ,Bar-Peled Y,Cipriano MJ,Striepen B.Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.Nature 2015;523:477-480[PMID:26176919 DOI:10.1038/nature14651]
133 Price AA,Sampson TR,Ratner HK,Grakoui A,Weiss DS.Cas9-mediated targeting of viral RNA in eukaryotic cells.Proc Natl Acad Sci USA 2015;112:6164-6169[PMID:25918406 DOI:10.1073/pnas.1422340112]
2 Burton MJ,Mabey DC.The global burden of trachoma:a review.PLo S Negl Trop Dis 2009;3:e460[PMID:19859534 DOI:10.1371/journal.pntd.0000460]
3 Whitcher JP,Srinivasan M,Upadhyay MP.Corneal blindness:a global perspective.Bull World Health Organ 2001;79:214-221[PMID:11285665]
4 Mohan RR,Rodier JT,Sharma A.Corneal gene therapy:basic science and translational perspective.Ocul Surf 2013;11:150-164[PMID:23838017 DOI:10.1016/j.jtos.2012.10.004]
5 Mohan RR,Schultz GS,Hong JW,Mohan RR,Wilson SE.Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access.Exp Eye Res 2003;76:373-383[PMID:12573666]
6 Mohan RR,Sharma A,Cebulko TC,Tandon A.Vector delivery technique affects gene transfer in the cornea in vivo.Mol Vis 2010;16:2494-2501[PMID:21139995]
7 Mohan RR,Sinha S,Tandon A,Gupta R,Tovey JC,Sharma A.Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea.PLo S One 2011;6:e18771[PMID:21533273 DOI:10.1371/journal.pone.0018771]
8 Mohan RR,Tandon A,Sharma A,Cowden JW,Tovey JC.Significant inhibition of corneal scarring in vivo with tissue-selective,targeted AAV5 decorin gene therapy.Invest Ophthalmol Vis Sci 2011;52:4833-4841[PMID:21551414 DOI:10.1167/iovs.11-7357]
9 Mohan RR,Tovey JC,Sharma A,Schultz GS,Cowden JW,Tandon A.Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.PLo S One 2011;6:e26432[PMID:22039486 DOI:10.1371/journal.pone.0026432]
10 Tandon A,Sharma A,Rodier JT,Klibanov AM,Rieger FG,Mohan RR.BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo.PLo S One 2013;8:e66434[PMID:23799103 DOI:10.1371/journal.pone.0066434]
11 Sharma A,Tandon A,Tovey JC,Gupta R,Robertson JD,Fortune JA,Klibanov AM,Cowden JW,Rieger FG,Mohan RR.Polyethylenimine-conjugated gold nanoparticles:Gene transfer potential and low toxicity in the cornea.Nanomedicine 2011;7:505-513[PMID:21272669 DOI:10.1016/j.nano.2011.01.006]
12 Smithies O,Gregg RG,Boggs SS,Koralewski MA,Kucherlapati RS.Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination.Nature 1985;317:230-234[PMID:2995814]
13 Thomas KR,Capecchi MR.Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.Cell 1987;51:503-512[PMID:2822260]
14 Vasquez KM,Marburger K,Intody Z,Wilson JH.Manipulating the mammalian genome by homologous recombination.Proc Natl Acad Sci USA 2001;98:8403-8410[PMID:11459982 DOI:10.1073/pnas.111009698]
15 Jackson AL,Bartz SR,Schelter J,Kobayashi SV,Burchard J,Mao M,Li B,Cavet G,Linsley PS.Expression profiling reveals offtarget gene regulation by RNAi.Nat Biotechnol 2003;21:635-637[PMID:12754523 DOI:10.1038/nbt831]
16 Birmingham A,Anderson EM,Reynolds A,Ilsley-Tyree D,Leake D,Fedorov Y,Baskerville S,Maksimova E,Robinson K,Karpilow J,Marshall WS,Khvorova A.3’UTR seed matches,but not overall identity,are associated with RNAi off-targets.Nat Methods 2006;3:199-204[PMID:16489337 DOI:10.1038/nmeth854]
17 Fedorov Y,Anderson EM,Birmingham A,Reynolds A,Karpilow J,Robinson K,Leake D,Marshall WS,Khvorova A.Off-target effects by si RNA can induce toxic phenotype.RNA 2006;12:1188-1196[PMID:16682561 DOI:10.1261/rna.28106]
18 Khan AA,Betel D,Miller ML,Sander C,Leslie CS,Marks DS.Transfection of small RNAs globally perturbs gene regulation by endogenous micro RNAs.Nat Biotechnol 2009;27:549-555[PMID:19465925 DOI:10.1038/nbt.1543]
19 Sledz CA,Holko M,de Veer MJ,Silverman RH,Williams BR.Activation of the interferon system by short-interfering RNAs.Nat Cell Biol 2003;5:834-839[PMID:12942087 DOI:10.1038/ncb1038]
20 Kim YG,Chandrasegaran S.Chimeric restriction endonuclease.Proc Natl Acad Sci USA 1994;91:883-887[PMID:7905633]
21 Kim YG,Li L,Chandrasegaran S.Insertion and deletion mutants of Fok I restriction endonuclease.J Biol Chem 1994;269:31978-31982[PMID:7989374]
22 Kim SS,Chen YM,O’Leary E,Witzgall R,Vidal M,Bonventre JV.A novel member of the RING finger family,KRIP-1,associates with the KRAB-A transcriptional repressor domain of zinc finger proteins.Proc Natl Acad Sci USA 1996;93:15299-15304[PMID:8986806]
23 Kim YG,Cha J,Chandrasegaran S.Hybrid restriction enzymes:zinc finger fusions to Fok I cleavage domain.Proc Natl Acad Sci USA 1996;93:1156-1160[PMID:8577732]
24 Carroll D.Genome engineering with targetable nucleases.Annu Rev Biochem 2014;83:409-439[PMID:24606144 DOI:10.1146/annurev-biochem-060713-035418]
25 Urnov FD,Rebar EJ,Holmes MC,Zhang HS,Gregory PD.Genome editing with engineered zinc finger nucleases.Nat Rev Genet 2010;11:636-646[PMID:20717154 DOI:10.1038/nrg2842]
26 Jackson SP,Bartek J.The DNA-damage response in human biology and disease.Nature 2009;461:1071-1078[PMID:19847258 DOI:10.1038/nature08467]
27 Moynahan ME,Jasin M.Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.Nat Rev Mol Cell Biol 2010;11:196-207[PMID:20177395 DOI:10.1038/nrm2851]
28 Lieber MR.The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.Annu Rev Biochem2010;79:181-211[PMID:20192759 DOI:10.1146/annurev.biochem.052308.093131]
29 Urnov FD,Miller JC,Lee YL,Beausejour CM,Rock JM,Augustus S,Jamieson AC,Porteus MH,Gregory PD,Holmes MC.Highly efficient endogenous human gene correction using designed zinc-finger nucleases.Nature 2005;435:646-651[PMID:15806097 DOI:10.1038/nature03556]
30 Deng H,Liu R,Ellmeier W,Choe S,Unutmaz D,Burkhart M,Di Marzio P,Marmon S,Sutton RE,Hill CM,Davis CB,Peiper SC,Schall TJ,Littman DR,Landau NR.Identification of a major coreceptor for primary isolates of HIV-1.Nature 1996;381:661-666[PMID:8649511 DOI:10.1038/381661a0]
31 Alkhatib G,Combadiere C,Broder CC,Feng Y,Kennedy PE,Murphy PM,Berger EA.CC CKR5:a RANTES,MIP-1alpha,MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.Science 1996;272:1955-1958[PMID:8658171]
32 Hütter G,Nowak D,Mossner M,Ganepola S,Müssig A,Allers K,Schneider T,Hofmann J,Kücherer C,Blau O,Blau IW,Hofmann WK,Thiel E.Long-term control of HIV by CCR5 Delta32/Delta32stem-cell transplantation.N Engl J Med 2009;360:692-698[PMID:19213682 DOI:10.1056/NEJMoa0802905]
33 Li L,Krymskaya L,Wang J,Henley J,Rao A,Cao LF,Tran CA,Torres-Coronado M,Gardner A,Gonzalez N,Kim K,Liu PQ,Hofer U,Lopez E,Gregory PD,Liu Q,Holmes MC,Cannon PM,Zaia JA,Di Giusto DL.Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.Mol Ther 2013;21:1259-1269[PMID:23587921DOI:10.1038/mt.2013.65]
34 Holt N,Wang J,Kim K,Friedman G,Wang X,Taupin V,Crooks GM,Kohn DB,Gregory PD,Holmes MC,Cannon PM.Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.Nat Biotechnol2010;28:839-847[PMID:20601939 DOI:10.1038/nbt.1663]
35 Perez EE,Wang J,Miller JC,Jouvenot Y,Kim KA,Liu O,Wang N,Lee G,Bartsevich VV,Lee YL,Guschin DY,Rupniewski I,Waite AJ,Carpenito C,Carroll RG,Orange JS,Urnov FD,Rebar EJ,Ando D,Gregory PD,Riley JL,Holmes MC,June CH.Establishment of HIV-1 resistance in CD4+T cells by genome editing using zinc-finger nucleases.Nat Biotechnol 2008;26:808-816[PMID:18587387 DOI:10.1038/nbt1410]
36 Tebas P,Stein D,Tang WW,Frank I,Wang SQ,Lee G,Spratt SK,Surosky RT,Giedlin MA,Nichol G,Holmes MC,Gregory PD,Ando DG,Kalos M,Collman RG,Binder-Scholl G,Plesa G,Hwang WT,Levine BL,June CH.Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.N Engl J Med 2014;370:901-910[PMID:24597865 DOI:10.1056/NEJMoa1300662]
37 Doyon Y,Vo TD,Mendel MC,Greenberg SG,Wang J,Xia DF,Miller JC,Urnov FD,Gregory PD,Holmes MC.Enhancing zincfinger-nuclease activity with improved obligate heterodimeric architectures.Nat Methods 2011;8:74-79[PMID:21131970 DOI:10.1038/nmeth.1539]
38 Miller JC,Holmes MC,Wang J,Guschin DY,Lee YL,Rupniewski I,Beausejour CM,Waite AJ,Wang NS,Kim KA,Gregory PD,Pabo CO,Rebar EJ.An improved zinc-finger nuclease architecture for highly specific genome editing.Nat Biotechnol 2007;25:778-785[PMID:17603475 DOI:10.1038/nbt1319]
39 Szczepek M,Brondani V,Büchel J,Serrano L,Segal DJ,Cathomen T.Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases.Nat Biotechnol 2007;25:786-793[PMID:17603476 DOI:10.1038/nbt1317]
40 Boch J,Scholze H,Schornack S,Landgraf A,Hahn S,Kay S,Lahaye T,Nickstadt A,Bonas U.Breaking the code of DNA binding specificity of TAL-type III effectors.Science 2009;326:1509-1512[PMID:19933107 DOI:10.1126/science.1178811]
41 Kay S,Hahn S,Marois E,Hause G,Bonas U.A bacterial effector acts as a plant transcription factor and induces a cell size regulator.Science2007;318:648-651[PMID:17962565 DOI:10.1126/science.1144956]
42 R?mer P,Hahn S,Jordan T,Strauss T,Bonas U,Lahaye T.Plant pathogen recognition mediated by promoter activation of the pepper Bs3 resistance gene.Science 2007;318:645-648[PMID:17962564 DOI:10.1126/science.1144958]
43 Bogdanove AJ,Voytas DF.TAL effectors:customizable proteins for DNA targeting.Science 2011;333:1843-1846[PMID:21960622DOI:10.1126/science.1204094]
44 Moscou MJ,Bogdanove AJ.A simple cipher governs DNA recognition by TAL effectors.Science 2009;326:1501[PMID:19933106 DOI:10.1126/science.1178817]
45 Hockemeyer D,Wang H,Kiani S,Lai CS,Gao Q,Cassady JP,Cost GJ,Zhang L,Santiago Y,Miller JC,Zeitler B,Cherone JM,Meng X,Hinkley SJ,Rebar EJ,Gregory PD,Urnov FD,Jaenisch R.Genetic engineering of human pluripotent cells using TALE nucleases.Nat Biotechnol 2011;29:731-734[PMID:21738127DOI:10.1038/nbt.1927]
46 Miller JC,Tan S,Qiao G,Barlow KA,Wang J,Xia DF,Meng X,Paschon DE,Leung E,Hinkley SJ,Dulay GP,Hua KL,Ankoudinova I,Cost GJ,Urnov FD,Zhang HS,Holmes MC,Zhang L,Gregory PD,Rebar EJ.A TALE nuclease architecture for efficient genome editing.Nat Biotechnol 2011;29:143-148[PMID:21179091 DOI:10.1038/nbt.1755]
47 Zhang F,Cong L,Lodato S,Kosuri S,Church GM,Arlotta P.Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription.Nat Biotechnol 2011;29:149-153[PMID:21248753 DOI:10.1038/nbt.1775]
48 Reyon D,Tsai SQ,Khayter C,Foden JA,Sander JD,Joung JK.FLASH assembly of TALENs for high-throughput genome editing.Nat Biotechnol 2012;30:460-465[PMID:22484455 DOI:10.1038/nbt.2170]
49 Huang P,Xiao A,Zhou M,Zhu Z,Lin S,Zhang B.Heritable gene targeting in zebrafish using customized TALENs.Nat Biotechnol2011;29:699-700[PMID:21822242 DOI:10.1038/nbt.1939]
50 Sander JD,Cade L,Khayter C,Reyon D,Peterson RT,Joung JK,Yeh JR.Targeted gene disruption in somatic zebrafish cells using engineered TALENs.Nat Biotechnol 2011;29:697-698[PMID:21822241 DOI:10.1038/nbt.1934]
51 Tesson L,Usal C,Ménoret S,Leung E,Niles BJ,Remy S,Santiago Y,Vincent AI,Meng X,Zhang L,Gregory PD,Anegon I,Cost GJ.Knockout rats generated by embryo microinjection of TALENs.Nat Biotechnol 2011;29:695-696[PMID:21822240DOI:10.1038/nbt.1940]
52 Wood AJ,Lo TW,Zeitler B,Pickle CS,Ralston EJ,Lee AH,Amora R,Miller JC,Leung E,Meng X,Zhang L,Rebar EJ,Gregory PD,Urnov FD,Meyer BJ.Targeted genome editing across species using ZFNs and TALENs.Science 2011;333:307[PMID:21700836 DOI:10.1126/science.1207773]
53 Deml B,Kariminejad A,Borujerdi RH,Muheisen S,Reis LM,Semina EV.Mutations in MAB21L2 result in ocular Coloboma,microcornea and cataracts.PLo S Genet 2015;11:e1005002[PMID:25719200 DOI:10.1371/journal.pgen.1005002]
54 Park CY,Kim J,Kweon J,Son JS,Lee JS,Yoo JE,Cho SR,Kim JH,Kim JS,Kim DW.Targeted inversion and reversion of the blood coagulation factor 8 gene in human i PS cells using TALENs.Proc Natl Acad Sci USA 2014;111:9253-9258[PMID:24927536DOI:10.1073/pnas.1323941111]
55 Ye L,Wang J,Beyer AI,Teque F,Cradick TJ,Qi Z,Chang JC,Bao G,Muench MO,Yu J,Levy JA,Kan YW.Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32mutation confers resistance to HIV infection.Proc Natl Acad Sci USA 2014;111:9591-9596[PMID:24927590 DOI:10.1073/pnas.1407473111]
56 Low BE,Krebs MP,Joung JK,Tsai SQ,Nishina PM,Wiles MV.Correction of the Crb1rd8 allele and retinal phenotype in C57BL/6 N mice via TALEN-mediated homology-directed repair.Invest Ophthalmol Vis Sci 2014;55:387-395[PMID:24346171 DOI:10.1167/iovs.13-13278]
57 Panda SK,Wefers B,Ortiz O,Floss T,Schmid B,Haass C,Wurst W,Kühn R.Highly efficient targeted mutagenesis in mice using TALENs.Genetics 2013;195:703-713[PMID:23979585 DOI:10.1534/genetics.113.156570]
58 Reddy P,Ocampo A,Suzuki K,Luo J,Bacman SR,Williams SL,Sugawara A,Okamura D,Tsunekawa Y,Wu J,Lam D,Xiong X,Montserrat N,Esteban CR,Liu GH,Sancho-Martinez I,Manau D,Civico S,Cardellach F,Del Mar O’Callaghan M,Campistol J,Zhao H,Campistol JM,Moraes CT,Izpisua Belmonte JC.Selective elimination of mitochondrial mutations in the germline by genome editing.Cell 2015;161:459-469[PMID:25910206DOI:10.1016/j.cell.2015.03.051]
59 Bacman SR,Williams SL,Pinto M,Peralta S,Moraes CT.Specific elimination of mutant mitochondrial genomes in patientderived cells by mito TALENs.Nat Med 2013;19:1111-1113[PMID:23913125 DOI:10.1038/nm.3261]
60 Li HL,Fujimoto N,Sasakawa N,Shirai S,Ohkame T,Sakuma T,Tanaka M,Amano N,Watanabe A,Sakurai H,Yamamoto T,Yamanaka S,Hotta A.Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.Stem Cell Reports 2015;4:143-154[PMID:25434822 DOI:10.1016/j.stemcr.2014.10.013]
61 Ding Q,Lee YK,Schaefer EA,Peters DT,Veres A,Kim K,Kuperwasser N,Motola DL,Meissner TB,Hendriks WT,Trevisan M,Gupta RM,Moisan A,Banks E,Friesen M,Schinzel RT,Xia F,Tang A,Xia Y,Figueroa E,Wann A,Ahfeldt T,Daheron L,Zhang F,Rubin LL,Peng LF,Chung RT,Musunuru K,Cowan CA.A TALEN genome-editing system for generating human stem cellbased disease models.Cell Stem Cell 2013;12:238-251[PMID:23246482 DOI:10.1016/j.stem.2012.11.011]
62 Kim Y,Kweon J,Kim A,Chon JK,Yoo JY,Kim HJ,Kim S,Lee C,Jeong E,Chung E,Kim D,Lee MS,Go EM,Song HJ,Kim H,Cho N,Bang D,Kim S,Kim JS.A library of TAL effector nucleases spanning the human genome.Nat Biotechnol 2013;31:251-258[PMID:23417094 DOI:10.1038/nbt.2517]
63 Menon T,Firth AL,Scripture-Adams DD,Galic Z,Qualls SJ,Gilmore WB,Ke E,Singer O,Anderson LS,Bornzin AR,Alexander IE,Zack JA,Verma IM.Lymphoid regeneration from genecorrected SCID-X1 subject-derived i PSCs.Cell Stem Cell 2015;16:367-372[PMID:25772073 DOI:10.1016/j.stem.2015.02.005]
64 Hu Z,Ding W,Zhu D,Yu L,Jiang X,Wang X,Zhang C,Wang L,Ji T,Liu D,He D,Xia X,Zhu T,Wei J,Wu P,Wang C,Xi L,Gao Q,Chen G,Liu R,Li K,Li S,Wang S,Zhou J,Ma D,Wang H.TALEN-mediated targeting of HPV oncogenes ameliorates HPVrelated cervical malignancy.J Clin Invest 2015;125:425-436[PMID:25500889 DOI:10.1172/JCI78206]
65 Cong L,Ran FA,Cox D,Lin S,Barretto R,Habib N,Hsu PD,Wu X,Jiang W,Marraffini LA,Zhang F.Multiplex genome engineering using CRISPR/Cas systems.Science 2013;339:819-823[PMID:23287718 DOI:10.1126/science.1231143]
66 Jinek M,Chylinski K,Fonfara I,Hauer M,Doudna JA,Charpentier E.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.Science 2012;337:816-821[PMID:22745249 DOI:10.1126/science.1225829]
67 Mali P,Aach J,Stranges PB,Esvelt KM,Moosburner M,Kosuri S,Yang L,Church GM.CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.Nat Biotechnol 2013;31:833-838[PMID:23907171DOI:10.1038/nbt.2675]
68 Mali P,Esvelt KM,Church GM.Cas9 as a versatile tool for engineering biology.Nat Methods 2013;10:957-963[PMID:24076990 DOI:10.1038/nmeth.2649]
69 Mali P,Yang L,Esvelt KM,Aach J,Guell M,Di Carlo JE,Norville JE,Church GM.RNA-guided human genome engineering via Cas9.Science 2013;339:823-826[PMID:23287722 DOI:10.1126/science.1232033]
70 Sternberg SH,Redding S,Jinek M,Greene EC,Doudna JA.DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.Nature 2014;507:62-67[PMID:24476820 DOI:10.1038/nature13011]
71 Sánchez-Rivera FJ,Jacks T.Applications of the CRISPR-Cas9system in cancer biology.Nat Rev Cancer 2015;15:387-395[PMID:26040603 DOI:10.1038/nrc3950]
72 Sánchez-Rivera FJ,Papagiannakopoulos T,Romero R,Tammela T,Bauer MR,Bhutkar A,Joshi NS,Subbaraj L,Bronson RT,Xue W,Jacks T.Rapid modelling of cooperating genetic events in cancer through somatic genome editing.Nature 2014;516:428-431[PMID:25337879 DOI:10.1038/nature13906]
73 Swiech L,Heidenreich M,Banerjee A,Habib N,Li Y,Trombetta J,Sur M,Zhang F.In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.Nat Biotechnol 2015;33:102-106[PMID:25326897 DOI:10.1038/nbt.3055]
74 Wang T,Wei JJ,Sabatini DM,Lander ES.Genetic screens in human cells using the CRISPR-Cas9 system.Science 2014;343:80-84[PMID:24336569 DOI:10.1126/science.1246981]
75 Wang H,Yang H,Shivalila CS,Dawlaty MM,Cheng AW,Zhang F,Jaenisch R.One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.Cell 2013;153:910-918[PMID:23643243 DOI:10.1016/j.cell.2013.04.025]
76 Zhou Y,Zhu S,Cai C,Yuan P,Li C,Huang Y,Wei W.Highthroughput screening of a CRISPR/Cas9 library for functional genomics in human cells.Nature 2014;509:487-491[PMID:24717434 DOI:10.1038/nature13166]
77 Shalem O,Sanjana NE,Hartenian E,Shi X,Scott DA,Mikkelsen TS,Heckl D,Ebert BL,Root DE,Doench JG,Zhang F.Genomescale CRISPR-Cas9 knockout screening in human cells.Science2014;343:84-87[PMID:24336571 DOI:10.1126/science.1247005]
78 Platt RJ,Chen S,Zhou Y,Yim MJ,Swiech L,Kempton HR,Dahlman JE,Parnas O,Eisenhaure TM,Jovanovic M,Graham DB,Jhunjhunwala S,Heidenreich M,Xavier RJ,Langer R,Anderson DG,Hacohen N,Regev A,Feng G,Sharp PA,Zhang F.CRISPR-Cas9 knockin mice for genome editing and cancer modeling.Cell 2014;159:440-455[PMID:25263330 DOI:10.1016/j.cell.2014.09.014]
79 Yu Z,Ren M,Wang Z,Zhang B,Rong YS,Jiao R,Gao G.Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila.Genetics 2013;195:289-291[PMID:23833182 DOI:10.1534/genetics.113.153825]
80 Friedland AE,Tzur YB,Esvelt KM,Colaiácovo MP,Church GM,Calarco JA.Heritable genome editing in C.elegans via a CRISPRCas9 system.Nat Methods 2013;10:741-743[PMID:23817069DOI:10.1038/nmeth.2532]
81 Dickinson DJ,Ward JD,Reiner DJ,Goldstein B.Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination.Nat Methods 2013;10:1028-1034[PMID:23995389 DOI:10.1038/nmeth.2641]
82 Cho SW,Kim S,Kim JM,Kim JS.Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.Nat Biotechnol 2013;31:230-232[PMID:23360966 DOI:10.1038/nbt.2507]
83 Hwang WY,Fu Y,Reyon D,Maeder ML,Tsai SQ,Sander JD,Peterson RT,Yeh JR,Joung JK.Efficient genome editing in zebrafish using a CRISPR-Cas system.Nat Biotechnol 2013;31:227-229[PMID:23360964 DOI:10.1038/nbt.2501]
84 Li D,Qiu Z,Shao Y,Chen Y,Guan Y,Liu M,Li Y,Gao N,Wang L,Lu X,Zhao Y,Liu M.Heritable gene targeting in the mouse and rat using a CRISPR-Cas system.Nat Biotechnol 2013;31:681-683[PMID:23929336 DOI:10.1038/nbt.2661]
85 Li W,Teng F,Li T,Zhou Q.Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems.Nat Biotechnol 2013;31:684-686[PMID:23929337DOI:10.1038/nbt.2652]
86 Yang H,Wang H,Shivalila CS,Cheng AW,Shi L,Jaenisch R.Onestep generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.Cell 2013;154:1370-1379[PMID:23992847 DOI:10.1016/j.cell.2013.08.022]
87 Hall AB,Basu S,Jiang X,Qi Y,Timoshevskiy VA,Biedler JK,Sharakhova MV,Elahi R,Anderson MA,Chen XG,Sharakhov IV,Adelman ZN,Tu Z.SEX DETERMINATION.A maledetermining factor in the mosquito Aedes aegypti.Science 2015;348:1268-1270[PMID:25999371 DOI:10.1126/science.aaa2850]
88 Kistler KE,Vosshall LB,Matthews BJ.Genome engineering with CRISPR-Cas9 in the mosquito Aedes aegypti.Cell Rep 2015;11:51-60[PMID:25818303 DOI:10.1016/j.celrep.2015.03.009]
89 Dong S,Lin J,Held NL,Clem RJ,Passarelli AL,Franz AW.Heritable CRISPR/Cas9-mediated genome editing in the yellow fever mosquito,Aedes aegypti.PLo S One 2015;10:e0122353[PMID:25815482 DOI:10.1371/journal.pone.0122353]
90 Basu S,Aryan A,Overcash JM,Samuel GH,Anderson MA,Dahlem TJ,Myles KM,Adelman ZN.Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in Aedes aegypti.Proc Natl Acad Sci USA 2015;112:4038-4043[PMID:25775608 DOI:10.1073/pnas.1502370112]
91 Gasiunas G,Barrangou R,Horvath P,Siksnys V.Cas9-cr RNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.Proc Natl Acad Sci USA 2012;109:E2579-E2586[PMID:22949671 DOI:10.1073/pnas.1208507109]
92 Sapranauskas R,Gasiunas G,Fremaux C,Barrangou R,Horvath P,Siksnys V.The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.Nucleic Acids Res 2011;39:9275-9282[PMID:21813460 DOI:10.1093/nar/gkr606]
93 Chen Y,Cao J,Xiong M,Petersen AJ,Dong Y,Tao Y,Huang CT,Du Z,Zhang SC.Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.Cell Stem Cell 2015;17:233-244[PMID:26145478 DOI:10.1016/j.stem.2015.06.001]
94 Wu Y,Liang D,Wang Y,Bai M,Tang W,Bao S,Yan Z,Li D,Li J.Correction of a genetic disease in mouse via use of CRISPRCas9.Cell Stem Cell 2013;13:659-662[PMID:24315440 DOI:10.1016/j.stem.2013.10.016]
95 Courtney DG,Moore JE,Atkinson SD,Maurizi E,Allen EH,Pedrioli DM,Mc Lean WH,Nesbit MA,Moore CB.CRISPR/Cas9DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting.Gene Ther 2016;23:108-112[PMID:26289666 DOI:10.1038/gt.2015.82]
96 Zhong H,Chen Y,Li Y,Chen R,Mardon G.CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes.Sci Rep 2015;5:8366[PMID:25666713 DOI:10.1038/srep08366]
97 Mohan RR,Sharma A,Netto MV,Sinha S,Wilson SE.Gene therapy in the cornea.Prog Retin Eye Res 2005;24:537-559[PMID:15955719 DOI:10.1016/j.preteyeres.2005.04.001]
98 Ran FA,Cong L,Yan WX,Scott DA,Gootenberg JS,Kriz AJ,Zetsche B,Shalem O,Wu X,Makarova KS,Koonin EV,Sharp PA,Zhang F.In vivo genome editing using Staphylococcus aureus Cas9.Nature 2015;520:186-191[PMID:25830891 DOI:10.1038/nature14299]
99 Ran FA,Hsu PD,Lin CY,Gootenberg JS,Konermann S,Trevino AE,Scott DA,Inoue A,Matoba S,Zhang Y,Zhang F.Double nicking by RNA-guided CRISPR Cas9 for enhanced genomeediting specificity.Cell 2013;154:1380-1389[PMID:23992846DOI:10.1016/j.cell.2013.08.021]
100 Suzuki K,Yu C,Qu J,Li M,Yao X,Yuan T,Goebl A,Tang S,Ren R,Aizawa E,Zhang F,Xu X,Soligalla RD,Chen F,Kim J,Kim NY,Liao HK,Benner C,Esteban CR,Jin Y,Liu GH,Li Y,Izpisua Belmonte JC.Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.Cell Stem Cell 2014;15:31-36[PMID:24996168 DOI:10.1016/j.stem.2014.06.016]
101 Nihongaki Y,Kawano F,Nakajima T,Sato M.Photoactivatable CRISPR-Cas9 for optogenetic genome editing.Nat Biotechnol2015;33:755-760[PMID:26076431 DOI:10.1038/nbt.3245]
102 Zetsche B,Gootenberg Jonathan S,Abudayyeh Omar O,Slaymaker Ian M,Makarova Kira S,Essletzbichler P,Volz Sara E,Joung J,van der Oost J,Regev A,Koonin Eugene V,Zhang F.Cpf1Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System.Cell 2015;163:759-771[DOI:10.1016/j.cell.2015.09.038]
103 Liang P,Xu Y,Zhang X,Ding C,Huang R,Zhang Z,Lv J,Xie X,Chen Y,Li Y,Sun Y,Bai Y,Songyang Z,Ma W,Zhou C,Huang J.CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.Protein Cell 2015;6:363-372[PMID:25894090 DOI:10.1007/s13238-015-0153-5]
104 Chang CJ,Bouhassira EE.Zinc-finger nuclease-mediated correction ofα-thalassemia in i PS cells.Blood 2012;120:3906-3914[PMID:23002118 DOI:10.1182/blood-2012-03-420703]
105 Chen YG,Forsberg MH,Khaja S,Ciecko AE,Hessner MJ,Geurts AM.Gene targeting in NOD mouse embryos using zinc-finger nucleases.Diabetes 2014;63:68-74[PMID:23974926 DOI:10.2337/db13-0192]
106 Cradick TJ,Keck K,Bradshaw S,Jamieson AC,Mc Caffrey AP.Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs.Mol Ther 2010;18:947-954[PMID:20160705 DOI:10.1038/mt.2010.20]
107 Didigu CA,Wilen CB,Wang J,Duong J,Secreto AJ,DanetDesnoyers GA,Riley JL,Gregory PD,June CH,Holmes MC,Doms RW.Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+T cells from HIV-1infection.Blood 2014;123:61-69[PMID:24162716 DOI:10.1182/blood-2013-08-521229]
108 Lombardo A,Genovese P,Beausejour CM,Colleoni S,Lee YL,Kim KA,Ando D,Urnov FD,Galli C,Gregory PD,Holmes MC,Naldini L.Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery.Nat Biotechnol 2007;25:1298-1306[PMID:17965707 DOI:10.1038/nbt1353]
109 Provasi E,Genovese P,Lombardo A,Magnani Z,Liu PQ,Reik A,Chu V,Paschon DE,Zhang L,Kuball J,Camisa B,Bondanza A,Casorati G,Ponzoni M,Ciceri F,Bordignon C,Greenberg PD,Holmes MC,Gregory PD,Naldini L,Bonini C.Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer.Nat Med 2012;18:807-815[PMID:22466705 DOI:10.1038/nm.2700]
110 Sebastiano V,Maeder ML,Angstman JF,Haddad B,Khayter C,Yeo DT,Goodwin MJ,Hawkins JS,Ramirez CL,Batista LF,Artandi SE,Wernig M,Joung JK.In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.Stem Cells 2011;29:1717-1726[PMID:21898685 DOI:10.1002/stem.718]
111 Zou J,Maeder ML,Mali P,Pruett-Miller SM,Thibodeau-Beganny S,Chou BK,Chen G,Ye Z,Park IH,Daley GQ,Porteus MH,Joung JK,Cheng L.Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.Cell Stem Cell 2009;5:97-110[PMID:19540188 DOI:10.1016/j.stem.2009.05.023]
112 Zou J,Sweeney CL,Chou BK,Choi U,Pan J,Wang H,Dowey SN,Cheng L,Malech HL.Oxidase-deficient neutrophils from X-linked chronic granulomatous disease i PS cells:functional correction by zinc finger nuclease-mediated safe harbor targeting.Blood 2011;117:5561-5572[PMID:21411759 DOI:10.1182/blood-2010-12-328161]
113 Sharma R,Anguela XM,Doyon Y,Wechsler T,De Kelver RC,Sproul S,Paschon DE,Miller JC,Davidson RJ,Shivak D,Zhou S,Rieders J,Gregory PD,Holmes MC,Rebar EJ,High KA.In vivo genome editing of the albumin locus as a platform for protein replacement therapy.Blood 2015;126:1777-1784[PMID:26297739 DOI:10.1182/blood-2014-12-615492]
114 Chen W,Liu J,Zhang L,Xu H,Guo X,Deng S,Liu L,Yu D,Chen Y,Li Z.Generation of the SCN1A epilepsy mutation in hi PS cells using the TALEN technique.Sci Rep 2014;4:5404[PMID:24953032 DOI:10.1038/srep05404]
115 Fadel HJ,Morrison JH,Saenz DT,Fuchs JR,Kvaratskhelia M,Ekker SC,Poeschla EM.TALEN knockout of the PSIP1 gene in human cells:analyses of HIV-1 replication and allosteric integrase inhibitor mechanism.J Virol 2014;88:9704-9717[PMID:24942577 DOI:10.1128/JVI.01397-14]
116 Huang X,Wang Y,Yan W,Smith C,Ye Z,Wang J,Gao Y,Mendelsohn L,Cheng L.Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient i PSCs After Genome Editing of the Sickle Point Mutation.Stem Cells 2015;33:1470-1479[PMID:25702619 DOI:10.1002/stem.1969]
117 Dreyer AK,H o ff m a n n D,L a c h m a n n N,A c k e r m a n n M,Steinemann D,Timm B,Siler U,Reichenbach J,Grez M,Moritz T,Schambach A,Cathomen T.TALEN-mediated functional correction of X-linked chronic granulomatous disease in patientderived induced pluripotent stem cells.Biomaterials 2015;69:191-200[PMID:26295532 DOI:10.1016/j.biomaterials.2015.07.057]
118 Zhang S,Li L,Kendrick SL,Gerard RD,Zhu H.TALEN-mediated somatic mutagenesis in murine models of cancer.Cancer Res2014;74:5311-5321[PMID:25070752 DOI:10.1158/0008-5472.CAN-14-0529]
119 Park CY,Kim DH,Son JS,Sung JJ,Lee J,Bae S,Kim JH,Kim DW,Kim JS.Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived i PSCs Using CRISPR-Cas9.Cell Stem Cell 2015;17:213-220[PMID:26212079 DOI:10.1016/j.stem.2015.07.001]
120 Karakikes I,Stillitano F,Nonnenmacher M,Tzimas C,Sanoudou D,Termglinchan V,Kong CW,Rushing S,Hansen J,Ceholski D,Kolokathis F,Kremastinos D,Katoulis A,Ren L,Cohen N,Gho JM,Tsiapras D,Vink A,Wu JC,Asselbergs FW,Li RA,Hulot JS,Kranias EG,Hajjar RJ.Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.Nat Commun 2015;6:6955[PMID:25923014 DOI:10.1038/ncomms7955]
121 Ochiai H,Miyamoto T,Kanai A,Hosoba K,Sakuma T,Kudo Y,Asami K,Ogawa A,Watanabe A,Kajii T,Yamamoto T,Matsuura S.TALEN-mediated single-base-pair editing identification of an intergenic mutation upstream of BUB1B as causative of PCS(MVA)syndrome.Proc Natl Acad Sci USA 2014;111:1461-1466[PMID:24344301 DOI:10.1073/pnas.1317008111]
122 Liu H,Chen Y,Niu Y,Zhang K,Kang Y,Ge W,Liu X,Zhao E,Wang C,Lin S,Jing B,Si C,Lin Q,Chen X,Lin H,Pu X,Wang Y,Qin B,Wang F,Wang H,Si W,Zhou J,Tan T,Li T,Ji S,Xue Z,Luo Y,Cheng L,Zhou Q,Li S,Sun YE,Ji W.TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys.CellStem Cell 2014;14:323-328[PMID:24529597 DOI:10.1016/j.stem.2014.01.018]
123 Wang H,Hu YC,Markoulaki S,Welstead GG,Cheng AW,Shivalila CS,Pyntikova T,Dadon DB,Voytas DF,Bogdanove AJ,Page DC,Jaenisch R.TALEN-mediated editing of the mouse Y chromosome.Nat Biotechnol 2013;31:530-532[PMID:23666012DOI:10.1038/nbt.2595]
124 Ousterout DG,Kabadi AM,Thakore PI,Majoros WH,Reddy TE,Gersbach CA.Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.Nat Commun 2015;6:6244[PMID:25692716 DOI:10.1038/ncomms7244]
125 Osborn MJ,Gabriel R,Webber BR,De Feo AP,Mc Elroy AN,Jarjour J,Starker CG,Wagner JE,Joung JK,Voytas DF,von Kalle C,Schmidt M,Blazar BR,Tolar J.Fanconi anemia gene editing by the CRISPR/Cas9 system.Hum Gene Ther 2015;26:114-126[PMID:25545896 DOI:10.1089/hum.2014.111]
126 Matano M,Date S,Shimokawa M,Takano A,Fujii M,Ohta Y,Watanabe T,Kanai T,Sato T.Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.Nat Med 2015;21:256-262[PMID:25706875 DOI:10.1038/nm.3802]
127 Yin H,Xue W,Chen S,Bogorad RL,Benedetti E,Grompe M,Koteliansky V,Sharp PA,Jacks T,Anderson DG.Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.Nat Biotechnol 2014;32:551-553[PMID:24681508 DOI:10.1038/nbt.2884]
128 Xue W,Chen S,Yin H,Tammela T,Papagiannakopoulos T,Joshi NS,Cai W,Yang G,Bronson R,Crowley DG,Zhang F,Anderson DG,Sharp PA,Jacks T.CRISPR-mediated direct mutation of cancer genes in the mouse liver.Nature 2014;514:380-384[PMID:25119044 DOI:10.1038/nature13589]
129 Long C,Mc Anally JR,Shelton JM,Mireault AA,Bassel-Duby R,Olson EN.Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA.Science 2014;345:1184-1188[PMID:25123483 DOI:10.1126/science.1254445]
130 Mandal PK,Ferreira LM,Collins R,Meissner TB,Boutwell CL,Friesen M,Vrbanac V,Garrison BS,Stortchevoi A,Bryder D,Musunuru K,Brand H,Tager AM,Allen TM,Talkowski ME,Rossi DJ,Cowan CA.Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9.Cell Stem Cell 2014;15:643-652[PMID:25517468 DOI:10.1016/j.stem.2014.10.004]
131 Schwank G,Koo BK,Sasselli V,Dekkers JF,Heo I,Demircan T,Sasaki N,Boymans S,Cuppen E,van der Ent CK,Nieuwenhuis EE,Beekman JM,Clevers H.Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.Cell Stem Cell 2013;13:653-658[PMID:24315439 DOI:10.1016/j.stem.2013.11.002]
132 Vinayak S,Pawlowic MC,Sateriale A,Brooks CF,Studstill CJ,Bar-Peled Y,Cipriano MJ,Striepen B.Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.Nature 2015;523:477-480[PMID:26176919 DOI:10.1038/nature14651]
133 Price AA,Sampson TR,Ratner HK,Grakoui A,Weiss DS.Cas9-mediated targeting of viral RNA in eukaryotic cells.Proc Natl Acad Sci USA 2015;112:6164-6169[PMID:25918406 DOI:10.1073/pnas.1422340112]